News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,617 Results
Type
Article (1450)
Company Profile (387)
Press Release (712779)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (248199)
Career Advice (3153)
Deals (35502)
Drug Delivery (68)
Drug Development (77709)
Employer Resources (7)
FDA (15979)
Job Trends (14469)
News (363153)
Policy (31804)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (8)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (8)
Academia (1807)
Academic (1)
Accelerated approval (2)
Adcomms (5)
Allergies (50)
Alliances (52913)
ALS (16)
Alzheimer's disease (856)
Antibody-drug conjugate (ADC) (64)
Approvals (16057)
Artificial intelligence (40)
ASCO (41)
Autoimmune disease (27)
Automation (3)
Bankruptcy (309)
Belgium (1)
Best Places to Work (11207)
BIO (8)
Biologics (1)
BIOSECURE Act (3)
Biosimilars (18)
BioSpace Insights (15)
Biotechnology (279)
Bladder cancer (35)
Brain cancer (7)
Breast cancer (92)
Cancer (667)
Cardiovascular disease (46)
Career advice (2655)
Career pathing (7)
CAR-T (36)
CDC (1)
CDMO (9)
Celiac Disease (1)
Cell therapy (86)
Cervical cancer (6)
Clinical research (63033)
Collaboration (81)
Commercialization (3)
Compensation (75)
Complete response letters (6)
COVID-19 (756)
CRISPR (6)
C-suite (41)
Cystic fibrosis (62)
Data (878)
Denatured (11)
Depression (17)
Dermatology (18)
Diabetes (75)
Diagnostics (5780)
Digital health (7)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (22)
Drug shortages (5)
Duchenne muscular dystrophy (16)
Earnings (93923)
Editorial (5)
Employer branding (1)
Employer resources (7)
Events (121115)
Executive appointments (29)
FDA (16396)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (72)
Gene editing (16)
Generative AI (5)
Gene therapy (58)
GLP-1 (110)
Government (3138)
Grass and pollen (2)
Guidances (164)
Healthcare (19066)
Hematology (19)
HIV (2)
Huntington's disease (6)
IgA nephropathy (8)
Immunology and inflammation (17)
Immuno-oncology (8)
Indications (21)
Infectious disease (781)
Inflammatory bowel disease (76)
Influenza (7)
Intellectual property (7)
Interviews (611)
IPO (15638)
IRA (5)
Job creations (3394)
Job search strategy (2164)
JPM (1)
Kidney cancer (4)
Labor market (5)
Layoffs (42)
Leadership (4)
Legal (8147)
Licensing (3)
Liver cancer (38)
Lung cancer (120)
Lymphoma (94)
Machine learning (1)
Manufacturing (80)
MASH (20)
Medical device (13224)
Medtech (13236)
Mergers & acquisitions (19639)
Metabolic disorders (169)
mRNA (9)
Multiple sclerosis (17)
NASH (6)
Netherlands (1)
Neurodegenerative disease (14)
Neuropsychiatric disorders (9)
Neuroscience (971)
NextGen: Class of 2026 (6352)
Non-profit (4807)
Now hiring (5)
Obesity (78)
Opinion (17)
Ovarian cancer (16)
Pain (12)
Pancreatic cancer (37)
Parkinson's disease (39)
Partnered (5)
Patents (29)
Patient recruitment (29)
Patient selection (1)
Peanut (34)
People (58888)
Pharmaceutical (66)
Pharmacy benefit managers (6)
Phase 1 (19380)
Phase 2 (27492)
Phase 3 (19396)
Pipeline (1586)
Policy (18)
Postmarket research (2788)
Preclinical (8283)
Press Release (72)
Prostate cancer (29)
Psychedelics (8)
Radiopharmaceuticals (200)
Rare diseases (148)
Real estate (6216)
Recruiting (3)
Regulatory (21123)
Reports (5)
Research institute (1745)
Resumes & cover letters (511)
Rett syndrome (2)
RNA editing (2)
RSV (11)
Schizophrenia (7)
Series A (12)
Series B (7)
Service/supplier (13)
Sickle cell disease (16)
Special edition (3)
Spinal muscular atrophy (95)
Sponsored (2)
Startups (3166)
Stomach cancer (2)
Supply chain (16)
Tariffs (4)
Vaccines (63)
Venture capital (6)
Weight loss (52)
Women's health (8)
Worklife (3)
Date
Today (6)
Last 7 days (43)
Last 30 days (132)
Last 365 days (2433)
2026 (1745)
2025 (2442)
2024 (21852)
2023 (39683)
2022 (42818)
2021 (48543)
2020 (50649)
2019 (43381)
2018 (34125)
2017 (32464)
2016 (33040)
2015 (39167)
2014 (35040)
2013 (31809)
2012 (33954)
2011 (34138)
2010 (35354)
Location
Africa (643)
Alabama (41)
Alaska (6)
Arizona (205)
Arkansas (7)
Asia (42225)
Australia (6750)
California (1875)
Canada (828)
China (141)
Colorado (85)
Connecticut (62)
Delaware (98)
Europe (92335)
Florida (217)
Georgia (67)
Hawaii (1)
Idaho (61)
Illinois (311)
India (9)
Indiana (158)
Iowa (2)
Japan (81)
Kansas (98)
Kentucky (8)
Louisiana (11)
Maine (52)
Maryland (373)
Massachusetts (1589)
Michigan (131)
Minnesota (240)
Missouri (22)
Montana (20)
Nebraska (22)
Nevada (15)
New Hampshire (42)
New Jersey (698)
New Mexico (18)
New York (496)
North Carolina (656)
North Dakota (6)
Northern California (904)
Ohio (98)
Oklahoma (5)
Oregon (25)
Pennsylvania (557)
Puerto Rico (4)
Rhode Island (1)
South America (1091)
South Carolina (3)
Southern California (800)
Tennessee (16)
Texas (246)
United States (8765)
Utah (42)
Virginia (35)
Washington D.C. (9)
Washington State (272)
Wisconsin (10)
714,617 Results for "66".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
June 9, 2026
·
3 min read
Press Releases
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
September 17, 2026
·
3 min read
Press Releases
RegCell Secures $66 Million of Additional Funding to Bring Nobel-Winning Immune Tolerance Science to the Clinic
September 15, 2026
·
6 min read
Press Releases
Theralase(R) Closes $CAN 2.66 Million Financing
April 10, 2026
·
6 min read
Press Releases
Abcuro Announces $66 Million Series D Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis
August 18, 2026
·
5 min read
Press Releases
ASCO 2026 | Oricell’s GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
June 1, 2026
·
6 min read
Press Releases
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
July 28, 2026
·
21 min read
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
·
3 min read
Press Releases
Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine
December 15, 2025
·
2 min read
Press Releases
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
October 6, 2025
·
5 min read
1 of 71,462
Next
